Sixteen teams have been selected for the Fall 2025 cohort of our Aspire Medtech investor-engagement program. Chosen from a competitive pool of applicants, these medtech companies are developing science and engineering innovations focused on improving patient outcomes and reducing healthcare costs through impactful design or application.
Over five weeks, teams will receive intensive training advancing their fundraising strategies, building out deal room materials, and working closely with investor-mentors to prepare for due diligence.
Aspire Medtech is a hybrid program that will take place virtually from October 14 to November 7, culminating in a three-day in-person workshop from November 12 to 14. This year, eight teams from Maryland have been selected, with the other eight coming from across the United States.
Discover more about the startups of the Fall 2025 cohort that are working on innovative medtech solutions like contactless remote patient monitoring to reduce hospital readmissions, an AI-powered stroke MRI analysis system for rapid diagnosis, and an oral appliance that instantly alleviates nasal congestion for patients with chronic sinus disease.
3D Orthobiologic Solutions (3DOS)
Herndon, Virginia
3DOS 3D-prints bone graft scaffolds for surgery, offering customizable, effective solutions for orthopedic procedures.
Caleo Biotechnologies Inc.
Germantown, Maryland
Caleo Biotechnologies is developing a next-generation, patient-first preclinical platform to address the limitations of current models for fibrotic diseases and cancer.
Cerevia Neurosciences
Rockville, Maryland
Cerevia Neurosciences is a full-stack neuromodulation platform that combines functional MRI, deep transcranial magnetic stimulation, and AI-driven personalization to treat dementia.
eMedicalSentry
Rockville, Maryland
eMedicalSentry provides AI-driven, contactless remote patient monitoring to reduce hospital readmissions and improve chronic care management.
Hidalga Technologies
Springdale, Arkansas
Hidalga Technologies is a healthcare software-as-a-service company that uses AI to automate oncology prior authorizations, cutting delays, denials, and costs.
Kandih Group
Silver Spring, Maryland
Kandih BioScience is a regulatory incubator that transforms bold science into safe, equitable healthcare solutions by combining toxicology expertise and tools that utilize AI to help innovators bring compliant medical products to market faster and more cost-effectively.
LSF Medical Solutions
Iowa City, Iowa
LSF Medical Solutions offers a highly sensitive remote lung monitoring device that provides real-time feedback for better, faster treatment decisions.
medara, Inc.
New York, New York
medara is developing a predictive AI-powered platform that analyzes imaging, clinical records, and patient factors to assess breast cancer risk, enable timely interventions, and reduce costs.
Microvitality
Boston, Massachusetts
Microvitality’s ingestible capsule delivers accurate small-intestine samples to detect gastrointestinal disorders early, guide treatment, and reduce misdiagnosis.
NeuroPred
Coralville, Iowa
NeuroPred is developing a stroke MRI analysis system leveraging AI which is designed for rapid diagnosis and improved patient outcomes.
SentiMetrix
Bethesda, Maryland
SentiMetrix is developing data science and machine learning–based video analysis solutions, to allow researchers and clinicians to examine human mobility with the aim of assessing recovery, monitoring aging populations, and improving patient care.
SimplusDx Inc.
Durham, North Carolina
SimplusDx Inc. is developing a point-of-care diagnostic platform for rapid, lab-quality therapeutic drug monitoring from a single drop of blood, starting with tacrolimus for organ transplant patients.
SinuStim
Baltimore, Maryland
SinuStim is developing an oral appliance that instantly alleviates nasal congestion for patients with chronic sinus disease, using gentle electrical pulses to regulate overactive nasal nerves.
SpringWear
Baltimore, Maryland
SpringWear makes affordable, home-ready hand exoskeletons that deliver immediate assistive function and long-term rehab gains through spring-assisted mechanics, selective motors, and sensor tracking.
VentSafe
San Francisco, California
VentSafe is developing a first-in-class multifrequency ventilator that uses ultra-high-frequency, low-pressure ventilation to reduce lung injury and improve outcomes in acute respiratory distress syndrome (ARDS) and critical care.
WearableDose, Inc.
Bowie, Maryland
WearableDose delivers real-time, AI-powered radiation monitoring and optimization through a wearable patch for cancer therapy, defense, and emergency response.
Access to a Dynamic Team of Investor-Mentors
Throughout Aspire, participating startups are paired with a carefully selected group of investor-mentors who bring decades of experience in angel investing, venture capital, medtech, and entrepreneurship. These mentors serve as trusted advisors, offering strategic insights and individualized feedback to help teams sharpen their value propositions, business models, and investment readiness.
We are pleased to welcome Katie Solley, VentureWell E-Team Program and Aspire alumna, and co-founder and CEO of Eyedea Medical, as our Aspire Medtech 2025 Entrepreneur-in-Residence. Solley will be joined by the following esteemed investor-mentors: Elaine Bolle, founder and board member, RTP Angel Fund; Jim Doscher, angel investor, Beacon Angels, and CEO, Digital Health Advisors; Tania Fernandez, founder and managing partner, DreamCatcher Ventures; Kim Frazier, partner, Capital Formation; Brent Goldstein, angel investor, NuFund Venture Group; LeKeisha Grant, innovation manager, Entrepreneurs’ Center; Ragan Hart, senior associate for Strategic Investments, WRF Capital; Marianne Hudson, angel investor, and executive director emeritus, Angel Capital Association; Ric Hughen, CEO, Linshom Medical; Terri Jordan, senior level business development executive and global leader; Loretta Little, managing director, WRF Capital; Sheila Narayan, managing director, Golden Seeds; Marquicia Pierce Henderson, founder and principal consultant, Ruby Leaf Media; Jamie Ryan, managing member and principal, JL Ryan Consulting LLC; Steven Weinstein, venture investor; and Isabel Wen, advisor and co-founder, Aurelius.
These investor-mentors are complemented by guest speakers, pitch coaches, and subject-matter experts who offer additional support throughout the program, ensuring that each team receives cross-disciplinary guidance and multiple touchpoints for growth.
Meet the Aspire Medtech Partners and Sponsors
VentureWell is proud to deliver the Fall 2025 Aspire Medtech cohort, along with generous support from TEDCO, and our legacy funding partner, The Lemelson Foundation, which is dedicated to supporting the power of invention to improve lives. In addition, we are also supported by Cooley LLP, an international law firm spurring the power of innovation through working with clients in the technology, life sciences, and high-growth industries.
We are thankful to the program partners, sponsors, and investors who offer their time and resources to support these startups!
Learn More About the Aspire Program
Since its inception in 2015, Aspire has had a significant positive impact on seed-stage startups. Across 221 startups, the teams have raised over $580 million in funding, with an 82% venture persistence rate. Aspire startups that are also E-Team Program grantees are eligible to receive matching investment from VentureWell.